Skip to content

The Motoric Cognitive Risk Syndrome in the Canadian Population

The Motoric Cognitive Risk Syndrome in the Canadian Population: Analysis of Baseline Assessment of the Canadian Longitudinal Study on Aging (CLSA)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03679026
Acronym
MCR-CardioV
Enrollment
1461
Registered
2018-09-20
Start date
2017-08-22
Completion date
2024-12-21
Last updated
2024-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Cognition Disorders in Old Age, Dementia

Brief summary

Cognition and locomotion are two human abilities controlled by the brain. Their decline is highly prevalent with aging, and is greater than the simple sum of their respective prevalence, suggesting a complex age-related interplay between cognition and locomotion. Recently, a systematic review and meta-analysis has provided evidence that poor gait performance predicts dementia and, in particular, has demonstrated that motoric cognitive risk (MCR) syndrome, which has been described in cognitively healthy individuals and combines subjective cognitive complaint with objective slow gait speed, is a pre-dementia syndrome. The uniqueness of motoric cognitive risk (MCR)syndrome is that it does not rely on a complex evaluation or laboratory investigations. Thus, it is easy to apply in population-based settings. The overall objective of the proposal is to examine the epidemiology of the newly reported motoric cognitive risk (MCR) syndrome, in the Quebec population using the database of the NuAge study.

Interventions

Participants' baseline characteristics will be summarized using means and standard deviations or frequencies and percentages, as appropriate.

Sponsors

Jewish General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
45 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Individuals eligible for this study will be participants of the NuAge study

Exclusion criteria

* Individuals not eligible for the NuAge study * dementia * mobility disability * no information about cognitive complaint * no measure of walking speed

Design outcomes

Primary

MeasureTime frameDescription
Cardio-vascular risk factors and diseases assessed using reported health condition1 daymedical history

Secondary

MeasureTime frameDescription
Cardio-vascular risk factors and diseases assessed using physical examination: HW ratio1 dayhip-waist ratio
Cardio-vascular risk factors and diseases assessed using physical examination: blood pressure1 day(value of systolic, diastolic when participants are seated in an upright position in a chair)
Disability and functional limitations1 dayDisability and functional limitations : ADL (activities of daily life)
Cardio-vascular risk factors and diseases assessed using physical examination: BMI1 daybody mass index
Cognitive performance1 dayProspective Memory Test (PMT)
physical and mental health1 dayNumber of drugs daily taken
Physical performance1 dayMuscle strength estimated using the handgrip strength
Depression1 daymeasured by the 10 items of the Center for Epidemiological Studies Short Depression Scale. Participants with a score of 10 or greater are considered as depressed. Scores with more than 2 missing items will be excluded.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026